| Typicality: | 0.522 |
| Saliency: | 0.372 |
| currently | 11 | temporal |
| in the united states | 4 | location |
| in cancer patients | 2 | location |
| vaccine → be in → clinical trials | 22 |
| vaccine → undergo → clinical trials | 14 |
| vaccine → be in → human trials | 4 |
| vaccine → be through → clinical trials | 3 |
| vaccine → go through → clinical trials | 3 |
| negative | neutral | positive |
| 0.097 | 0.694 | 0.209 |
| Raw frequency | 46 |
| Normalized frequency | 0.372 |
| Modifier score | 0.850 |
| Perplexity | 58.874 |